[PDF][PDF] Incremental long-term benefit of drug therapies for chronic obstructive pulmonary disease in quality of life but not mortality: a network meta-analysis
Q Pan, J Sun, S Gao, Z Liu… - Archives of …, 2024 - archivesofmedicalscience.com
Introduction: The latest evidence revealed that dupilumab, an interleukin-4 (IL-4) and
interleukin-13 (IL-13) blocker, significantly reduces the exacerbation risk in patients with …
interleukin-13 (IL-13) blocker, significantly reduces the exacerbation risk in patients with …